Insurers, FDA team up to find problem drugs
Wall Street Journal (subscription required), April 15, 2008
WellPoint Inc. is collaborating with the Food and Drug Administration to launch one of the first real-time drug-surveillance systems. Starting in 2009, Wellpoint will systematically scan the medical information of more than half of its 35 million members to look for hidden patterns or jumps in medical problems that might be linked to certain medication or combination of drugs. The drug-safety monitoring system currently used by the FDA has been criticized for spotty, slow and passive.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- PCI: Concerns Mount About Appropriateness
- MA an Insurance Proving Ground for Providers
- Transforming Cancer Care
- Targeting Self-Insured Populations